[HTML][HTML] Role of OCT4 in cancer stem-like cells and chemotherapy resistance

IS Mohiuddin, SJ Wei, MH Kang - … Acta (BBA)-Molecular Basis of Disease, 2020 - Elsevier
Cancer stem-like cells (CSCs) contribute to the tumorigenicity, progression, and
chemoresistance of cancers. It is not known whether CSCs arise from normal stem cells or if …

[HTML][HTML] Mutations of p53 associated with pancreatic cancer and therapeutic implications

IA Voutsadakis - Annals of hepato-biliary-pancreatic surgery, 2021 - synapse.koreamed.org
Pancreatic adenocarcinoma is a malignancy with rising incidence and grim prognosis.
Despite improvements in therapeutics for treating metastatic pancreatic cancer, this disease …

Germline stem cells in human

H Cheng, D Shang, R Zhou - Signal transduction and targeted therapy, 2022 - nature.com
The germline cells are essential for the propagation of human beings, thus essential for the
survival of mankind. The germline stem cells, as a unique cell type, generate various states …

METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma

J Wei, Y Yin, J Zhou, H Chen, J Peng… - Journal of cellular …, 2020 - Wiley Online Library
Testicular germ cell tumours (TGCTs) rank as the most common malignancy in men aged 20‐
34 years, and seminomas are the most type of TGCTs. As a crucial anti‐tumour agent with …

[HTML][HTML] The m6A methyltransferase METTL3 regulates autophagy and sensitivity to cisplatin by targeting ATG5 in seminoma

H Chen, Y Xiang, Y Yin, J Peng, D Peng… - Translational …, 2021 - ncbi.nlm.nih.gov
Background Our previous work shows Autophagy enhanced resistance to cisplatin in
seminoma. The expression of the N6-methyladenosine (m6A) methyltransferases METTL3 …

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer

L Wang, L Ma, F Xu, W Zhai, S Dong, L Yin… - Thoracic …, 2018 - Wiley Online Library
Lung cancer is the leading cause of cancer‐associated death, and non‐small cell lung
cancer (NSCLC) accounts for 85% of all lung cancer cases. Many drugs have been used to …

Epigenetic drugs and their molecular targets in testicular germ cell tumours

S Jostes, D Nettersheim, H Schorle - Nature Reviews Urology, 2019 - nature.com
Current treatment regimens for type II testicular germ cell tumours (TGCTs) achieve cure
rates of≥ 95%; however, 1–5% of TGCTs develop resistance to standard platinum-based …

Disulfiram overcomes cisplatin resistance in human embryonal carcinoma cells

S Schmidtova, K Kalavska, K Gercakova, Z Cierna… - Cancers, 2019 - mdpi.com
Cisplatin resistance in testicular germ cell tumors (TGCTs) is a clinical challenge. We
investigated the underlying mechanisms associated with cancer stem cell (CSC) markers …

Near-infrared photoimmunotherapy (NIR-PIT) in urologic cancers

H Fukushima, B Turkbey, PA Pinto, A Furusawa… - Cancers, 2022 - mdpi.com
Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-
targeted therapy that induces rapid cancer cell death by systemically administering an …

The functional status of DNA repair pathways determines the sensitization effect to cisplatin in non-small cell lung cancer cells

P Chen, J Li, YC Chen, H Qian, YJ Chen, JY Su, M Wu… - Cellular oncology, 2016 - Springer
Purpose Cisplatin can cause a variety of DNA crosslink lesions including intra-strand and
inter-strand crosslinks (ICLs), which are associated with the sensitivity of cancer cells to …